DUSA PHARMACEUTICALS INC
10-Q, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: DUSA PHARMACEUTICALS INC, 10-Q, EX-10, 2000-11-14
Next: INSURANCE AUTO AUCTIONS INC /CA, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This Schedule contains summary financial information extracted from (A) the
Company's unaudited consolidated balance sheets, consolidated statements of
operations, and consolidated statements of cash flows and is qualified in its
entirety by reference to such and (B) the Form 10-Q for the fiscal quarter
ending September 30, 2000.
</LEGEND>
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                       2,104,023
<SECURITIES>                                59,686,742
<RECEIVABLES>                                  139,583
<ALLOWANCES>                                         0
<INVENTORY>                                    882,711
<CURRENT-ASSETS>                            64,450,887
<PP&E>                                       1,237,115
<DEPRECIATION>                                 181,887
<TOTAL-ASSETS>                              67,407,396
<CURRENT-LIABILITIES>                        1,344,951
<BONDS>                                              0
                                0
                                          0
<COMMON>                                    94,720,674
<OTHER-SE>                                   1,338,854
<TOTAL-LIABILITY-AND-EQUITY>                67,407,396
<SALES>                                        139,583
<TOTAL-REVENUES>                             1,084,058
<CGS>                                          139,583
<TOTAL-COSTS>                                  670,725
<OTHER-EXPENSES>                             2,027,420
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (1,614,087)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (1,614,087)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,614,087)
<EPS-BASIC>                                      (.12)
<EPS-DILUTED>                                    (.12)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission